Junliang Ma
Overview
Explore the profile of Junliang Ma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
732
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lu T, Deng T, Long Y, Li J, Hu A, Hu Y, et al.
J Med Internet Res
. 2024 Nov;
26:e56795.
PMID: 39527799
Background: Pulmonary rehabilitation (PR) has been shown to effectively support postsurgical recovery in patients with lung cancer (LC) at various stages. While digital PR programs offer a potential solution to...
2.
Deng T, Song J, Tuo J, Wang Y, Li J, Suen L, et al.
Heliyon
. 2024 Jul;
10(12):e32821.
PMID: 38975138
Postoperative pulmonary complications (PPCs) are associated with high mortality rates after lung cancer surgery. Although some studies have discussed the different risk factors for PPCs, the relationship between these factors...
3.
Wang Z, Li W, Ma J, Liu B, Wang W, Liu Z
Materials (Basel)
. 2024 Jun;
17(12).
PMID: 38930348
Aluminum (Al) and its alloys are widely used in various fields due to their excellent physical properties. Although many efforts have been made to fabricate an Al-based composite, they usually...
4.
Ma J, Chen S, Ren X, Han H, Gong M, Song Y, et al.
Afr Health Sci
. 2024 Feb;
23(3):540-546.
PMID: 38357145
Background: Patients are prone to intestinal dysfunction after esophagectomy. The value of preoperative bowel preparation before esophagectomy is controversial. There is a lack of evidence as to whether preoperative bowel...
5.
Yang Z, Wang S, Yang H, Jiang Y, Zhu L, Zheng B, et al.
J Thorac Cardiovasc Surg
. 2024 Feb;
168(4):1245-1258.e17.
PMID: 38342430
Background: Neoadjuvant immunotherapy has ushered in a new era of perioperative treatment for resectable non-small cell lung cancer (NSCLC). However, large-scale data for verifying the efficacy and optimizing the therapeutic...
6.
Ma J, Chen S, Su M, Wang W
Medicine (Baltimore)
. 2023 Apr;
102(14):e33388.
PMID: 37026938
Esophageal cancer (EC) is a serious threat to human health. The expression of fibronectin 1 (FN1) in esophageal squamous cell carcinoma (ESCC) remains controversial. The purpose of this study was...
7.
Ma J, Luo Y, Liu Y, Chen C, Chen A, Liang L, et al.
Korean J Physiol Pharmacol
. 2022 Dec;
27(1):61-73.
PMID: 36575934
Esophageal squamous cell carcinoma (ESCC) is a kind of malignant tumor with high incidence and mortality in the digestive system. The aim of this study is to explore the function...
8.
Zhang H, Ma J, Gao Z, Guo F, Xu S, Hou G, et al.
Materials (Basel)
. 2022 May;
15(10).
PMID: 35629744
Nowadays, both the ferrite phase and B2-structured intermetallic in the Fe-Cr-Al alloy system are developed as porous materials, which have been further applied as high-temperature filter materials in industry. This...
9.
Liu Y, Luo G, Tang Q, Song Y, Liu D, Wang H, et al.
Bioengineered
. 2022 May;
13(5):11832-11843.
PMID: 35543357
To explore the METTL14-dependent mA modification mechanism involved in the development of atherosclerosis. Oxidized low-density lipoprotein (ox-LDL) and the HUVEC cell line were used to establish an atherosclerosis cell model...
10.
Ma J, Chen S, Liu Y, Han H, Gong M, Song Y
Genes Genomics
. 2022 Feb;
44(10):1243-1258.
PMID: 35150402
Background: It has been reported that tumor-associated macrophages (TAMs) participate in modulating the progression of cancer in the tumor microenvironment. However, the crosstalk between TAMs and non-small cell lung cancer...